Pemazyre Interactions
There are 296 drugs known to interact with Pemazyre (pemigatinib), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 78 are major, 216 are moderate, and 2 are minor.
- View all 296 medications that may interact with Pemazyre
- View Pemazyre alcohol/food interactions (1)
- View Pemazyre disease interactions (1)
Most frequently checked interactions
View interaction reports for Pemazyre (pemigatinib) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alhemo (concizumab)
- alpha-lipoic acid
- alprazolam
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- Amondys 45 (casimersen)
- ampicillin
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Aspirin Low Strength (aspirin)
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- clonazepam
- Cymbalta (duloxetine)
- melatonin
- metformin
- nitroglycerin
- Ozempic (semaglutide)
- pantoprazole
- Vitamin D3 (cholecalciferol)
Pemazyre alcohol/food interactions
There is 1 alcohol/food interaction with Pemazyre (pemigatinib).
Pemazyre disease interactions
There is 1 disease interaction with Pemazyre (pemigatinib) which include:
Report options
QR code containing a link to this page
More about Pemazyre (pemigatinib)
- Pemazyre consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
